Stock Earnings KNSA Shares Experience Decline in Value The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Insiders Updates Kiniksa Pharmaceuticals International Plc (KNSA) receives a Buy rating from Citigroup Kiniksa Pharmaceuticals International Plc’s recent filing unveils that its CHIEF COMMERCIAL OFFICER Moat Ross unloaded Company’s shares for reported $0.18
Insiders Updates Examining the Potential Price Growth of Kiniksa Pharmaceuticals International Plc (KNSA) Kiniksa Pharmaceuticals International Plc’s filing revealed that its Officer Moat Ross acquired Company’s shares for reported $1.61 million on Apr